THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES has a total of 22 patent applications. Its first patent ever was published in 2014. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are FOND THE ARK, UCL BUSINESS LTD and JUNO THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | United States | 5 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | Canada | 3 | |
#5 | Republic of Korea | 2 | |
#6 | Brazil | 1 | |
#7 | Peru | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Medical technology | |
#5 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Analysing materials | |
#6 | Diagnosis and surgery | |
#7 | Acyclic or carbocyclic compounds | |
#8 | Measuring microorganism processes | |
#9 | Organic chemistry methods | |
#10 | Syringes |
# | Name | Total Patents |
---|---|---|
#1 | Schiller John T | 2 |
#2 | Lederman Robert J | 2 |
#3 | Lowy Douglas R | 2 |
#4 | Cuburu Nicolas | 2 |
#5 | Qin Haiying | 2 |
#6 | Allan David S J | 1 |
#7 | Bulea Thomas | 1 |
#8 | Ho Mitchell | 1 |
#9 | Schneider Joel | 1 |
#10 | Lovell Michael W | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020168179A1 | Handgrip relaxometer system | |
WO2020163868A1 | Genetically modified hematopoietic stem and progenitor cells (hspcs) and mesenchymal cells as a platform to reduce or prevent metastasis, treat autoimmune and inflammatory disorders, and rebalance the immune milieu and dysregulated niches | |
WO2020160502A1 | Methods and compositions for detecting transfusion-transmitted pathogens | |
WO2020160157A1 | Detection of bcl-2 family heterodimer complexes and use thereof | |
WO2020132214A2 | Ebola virus glycoprotein-specific monoclonal antibodies and uses thereof | |
WO2019165122A1 | Neutralizing antibodies to hiv-1 env and their use | |
BR112020001255A2 | immunogenic compositions of neisseria meningitidis | |
EP3355802A1 | Endo-cameral closure device | |
US2018111992A1 | Dual specific anti-CD22-anti-CD19 chimeric antigen receptors | |
US2018110850A1 | Immunogenic RSV polypeptides |